# GeneDx Holdings Corp.: Form 8-K, filed Jun 16, 2026

- Company: [GeneDx Holdings Corp.](/companies/wgs.md) (CIK 1818331)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 08:39 ET
- Period: 2026-06-15
- Accession: 0001628280-26-043431
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818331/000162828026043431/wgs-20260615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818331/000162828026043431/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818331/000162828026043431/wgs-20260615.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-043431. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.
